Show simple item record

dc.contributor.authorHenkel, Ralf
dc.contributor.authorAgarwal, Ashok
dc.contributor.authorFarkouh, Ala'a
dc.date.accessioned2024-02-13T10:32:41Z
dc.date.available2024-02-13T10:32:41Z
dc.date.issued2023
dc.identifier.citationAgarwal, A., Farkouh, A.A., Saleh, R., Hamoda, T.A.A.A.M., Harraz, A.M., Kavoussi, P., Arafa, M., Salvio, G., Rambhatla, A., Toprak, T. and Gül, M., 2023. Controversy and consensus on indications for sperm DNA fragmentation testing in male infertility: A global survey, current guidelines, and expert recommendations. The world journal of men's health, 41(3), p.575.en_US
dc.identifier.issn22874208
dc.identifier.urihttp://hdl.handle.net/10566/9297
dc.description.abstractPurpose: Sperm DNA fragmentation (SDF) testing was recently added to the sixth edition of the World Health Organization laboratory manual for the examination and processing of human semen. Many conditions and risk factors have been associated with elevated SDF; therefore, it is important to identify the population of infertile men who might benefit from this test. The purpose of this study was to investigate global practices related to indications for SDF testing, compare the relevant professional society guideline recommendations, and provide expert recommendations. Materials and methods: Clinicians managing male infertility were invited to take part in a global online survey on SDF clinical practices. This was conducted following the CHERRIES checklist criteria. The responses were compared to professional society guideline recommendations related to SDF and the appropriate available evidence. Expert recommendations on indications for SDF testing were then formulated, and the Delphi method was used to reach consensus. Results: The survey was completed by 436 experts from 55 countries. Almost 75% of respondents test for SDF in all or some men with unexplained or idiopathic infertility, 39% order it routinely in the work-up of recurrent pregnancy loss (RPL), and 62.2% investigate SDF in smokers. While 47% of reproductive urologists test SDF to support the decision for varicocele repair surgery when conventional semen parameters are normal, significantly fewer general urologists (23%; p=0.008) do the same. Nearly 70% would assess SDF before assisted reproductive technologies (ART), either always or for certain conditions. Recurrent ART failure is a common indication for SDF testing. Very few society recommendations were found regarding SDF testing. Conclusions: This article presents the largest global survey on the indications for SDF testing in infertile men, and demonstrates diverse practices. Furthermore, it highlights the paucity of professional society guideline recommendations. Expert recommendations are proposed to help guide clinicians.en_US
dc.language.isoenen_US
dc.publisherKorean Society for Sexual Medicine and Andrologyen_US
dc.subjectDelphi methoden_US
dc.subjectDNA fragmentationen_US
dc.subjectMale infertilityen_US
dc.subjectPractice guidelinesen_US
dc.subjectSpermen_US
dc.titleControversy and consensus on indications for sperm dna fragmentation testing in male infertility: a global survey, current guidelines, and expert recommendationsen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record